Huperzine A
Also known as: Huperzia serrata extract, Chinese club moss extract, HupA
The club-moss acetylcholinesterase inhibitor — an Alzheimer's drug in China, a cognitive nootropic elsewhere.
In short
Huperzine A is an alkaloid from Chinese club moss (Huperzia serrata) that inhibits acetylcholinesterase — the enzyme that breaks down acetylcholine, the brain's key learning and memory neurotransmitter. By preserving acetylcholine, it boosts cholinergic signaling; the same mechanism underlies donepezil and other Alzheimer's drugs. In China, huperzine A is an approved drug for Alzheimer's disease, backed by a large trial; in the US it is sold as a memory supplement, with meta-analyses showing modest cognitive benefits and good tolerability. The effects are real but incremental — a mild cognitive assist, not limitless, and its drug-like potency means dosing and medication interactions deserve care.
- Alkaloid from Huperzia serrata (Chinese club moss)
- Potent, reversible acetylcholinesterase inhibitor
- Approved Alzheimer's drug in China; supplement in the US
- Modest cognition benefits in meta-analyses; good tolerability
What is Huperzine A?
Huperzine A is the rare botanical that became a pharmaceutical. Extracted from a humble club moss, it works by the same mechanism as prescription Alzheimer's drugs — keeping acetylcholine in the synapse longer — and China licensed it as a medicine decades ago. Western supplement culture took the hint: huperzine A became a nootropic staple for students and biohackers. The evidence supports a modest, real effect on memory in healthy and impaired populations, but this is an ingredient with drug-like pharmacology: long half-life, accumulation potential, and cholinergic side effects at high doses. Respect the molecule.
Where it comes from
Natural sources
- Alkaloid of Huperzia serrata, a club moss used in traditional Chinese medicine for contusions and memory
- First isolated in the 1980s by Chinese researchers
How it's made
Supplements supply 50–200 mcg tablets/capsules; Chinese pharmaceutical formulations (tablets, injections) used for Alzheimer's.
What it does in products
Benefits
Memory and cognition
strong evidenceMeta-analyses of ~20 trials report significant, modest improvements in memory scores in both Alzheimer's patients and healthy adults; a large Chinese trial found benefit comparable to donepezil in some measures.
Alzheimer's symptom management
moderate evidenceUsed clinically in China for over two decades with documented cognitive stabilization; Western evidence is smaller but consistent.
Nootropic use in healthy people
moderate evidenceSmall trials show improved memory consolidation in students and older adults; effects are modest and individual.
Side effects & safety
Safety considerations
- Avoid — insufficient data, and cholinergic effects on the developing brain are unstudied.
- Alzheimer's drugs (donepezil, rivastigmine, galantamine) — additive cholinergic effects; do not combine
- Beta-blockers — additive bradycardia risk
- Anticholinergic drugs — opposing effects
- Not for: Bradycardia, heart block, or asthma (cholinergic sensitivity)
- Not for: Epilepsy — seizure reports exist at high doses
How it's used
In supplements
50–200 mcg/day, often cycled (e.g., 5 days on, 2 off) due to ~10–14 hour half-life and accumulation.
In skincare
Not a topical ingredient.
Regulatory status
- Sold as a dietary supplement in the US; approved as a drug for Alzheimer's in China. Not FDA-approved for any condition.
- Not applicable.
Popular products containing Huperzine A
- Double Wood Huperzine A — 200 mcg capsulesDouble Wood Supplements · Supplement
- Source Naturals Huperzine A — 100 mcg tabletsSource Naturals · Supplement
- Nootropics Depot Huperzine A — Lab-tested powder/capsulesNootropics Depot · Supplement
Product names and brands are shown for reference and belong to their respective owners.
The acetylcholine economy
Learning and memory depend on cholinergic neurons that release acetylcholine at synapses; acetylcholinesterase ends each signal by breaking it down. Huperzine A reversibly inhibits this enzyme, extending each signal's lifetime — the same strategy as donepezil. Its inhibition is potent and long-acting, which is both the benefit and the dosing hazard: effects accumulate with daily use.
Cycling and accumulation
With a half-life of 10–14 hours, daily dosing accumulates to a higher steady state over about a week. Nootropic users commonly cycle (days on/off or weeks on, weeks off) to avoid cholinergic overload — insomnia, twitching, and nausea signal the ceiling.
Frequently asked questions
Does huperzine A work immediately?
Some users notice acute effects, but trial benefits develop over weeks. It is not an Adderall-like stimulant; it modulates a learning pathway.
Can I take huperzine A with Alpha-GPC or other cholinergics?
They are additive — combinations amplify both benefit and side effects. Start low, dose separately, and watch for cholinergic symptoms.
Is huperzine A safe long-term?
Chinese clinical use spans decades with a good safety record at therapeutic doses, but Western long-term data are thin. Cycling and staying at 200 mcg/day or less is prudent.
The bottom line
Huperzine A is a genuine, drug-like cognitive aid with real trial support — a modest memory enhancer that deserves dosing discipline rather than casual stacking.
References
- Huperzine A for Alzheimer's disease: meta-analysis. Cochrane Database of Systematic Reviews. https://pubmed.ncbi.nlm.nih.gov/23859222/
- Huperzine A: pharmacology and clinical efficacy. PubMed Central. https://pubmed.ncbi.nlm.nih.gov/23820766/
- Huperzine A in healthy volunteers and memory. PubMed. https://pubmed.ncbi.nlm.nih.gov/16688993/